ArticleJournal of cancer research and clinical oncology2019

ΔNp63 transcript loss in bladder cancer constitutes an independent molecular predictor of TaT1 patients post-treatment relapse and progression.

Maria-Alexandra Papadimitriou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.